...
首页> 外文期刊>Journal of Young Pharmacists >Retrospective Drug Utilization of Cardiovascular Drugs in A Tertiary Healthcare Setting in Malaysia
【24h】

Retrospective Drug Utilization of Cardiovascular Drugs in A Tertiary Healthcare Setting in Malaysia

机译:马来西亚三级医疗机构对心血管药物的回顾性药物利用

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objective: The general objective of this study was to analyse the utilization patterns of cardiovascular drugs among a sample of patients in a tertiary healthcare setting during the preceding two years. Methodology: This study design was exploratory, descriptive and retrospective. Data were extracted from the case sheets pertaining to patients who had been admitted to the study site and administered CV drugs during the preceding two years, into customized data collection format. A total of 100 patient data were obtained, based on the inclusion criteria. The data collected were then analyzed by SPSS v22. Results: A total of 29 males (28.4%) and 73 females (71.6%) data were analysed. The majority of the patients were in the age range 50-55 years. Among the ethnic groups, the Malays (72.5%) were the highest, followed by Indians (14.7%) and the Chinese (11.8%). The co-morbidities observed among the sample are depicted in Table 1 with p 0.001 (Chi-square test). It was noted that the combination of HTN +DM was the most observed (18.6%). Among the CV medications, statins (54.9%), antiplatelets (39.2%), anticoagulants (26.5%) and beta-blockers (33.3%) were more commonly used for these patients. Conclusion: The usage of all these medications was in accordance with the national guidelines in Malaysia. The mean CV drug count was 3.16, which though optimal might be indicative of potential non-compliance among patients.
机译:目的:本研究的总体目的是分析前两年在三级医疗机构中样本患者中心血管药物的利用模式。方法:本研究设计具有探索性,描述性和回顾性。从病例表中提取数据,这些数据与前两年入院并使用了CV药物的患者有关,以定制的数据收集格式。根据纳入标准,总共获得了100位患者数据。然后通过SPSS v22分析收集的数据。结果:总共分析了29例男性(28.4%)和73例女性(71.6%)数据。大多数患者年龄在50-55岁之间。在各族裔中,马来人(72.5%)最高,其次是印度人(14.7%)和华人(11.8%)。表1中描述了样本中观察到的共发病率,p <0.001(卡方检验)。值得注意的是,HTN + DM的组合最多(18.6%)。在这些心血管药物中,这些患者更常使用他汀类药物(54.9%),抗血小板药物(39.2%),抗凝剂(26.5%)和β受体阻滞剂(33.3%)。结论:所有这些药物的使用均符合马来西亚的国家指南。平均CV药物计数为3.16,尽管最佳,但可能表明患者之间可能存在违规情况。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号